AGP Limited, a Pakistani pharmaceutical company, has approved an arrangement with an associated company to manufacture and market Viagra in the country, with the product expected to be launched in May 2026.
The listed pharmaceutical disclosed the development in a notice to the Pakistan Stock Exchange (PSX) on Thursday.
“The Board of Directors of AGP Limited, at its meeting held on April 29, 2026, approved the entering into an arrangement with one of its associated companies, under which the company shall undertake contract manufacturing and marketing services for the pharmaceutical product ‘Viagra’,” read the notice.
Under the proposed arrangement, AGP Limited shall be the Contract Manufacturing Organization (CMO) for the product and shall also be granted marketing rights to undertake commercialisation and promotion of such product in Pakistan.
“The necessary agreements are being finalised between the parties and the product is expected to be launched in the market during May 2026, subject to completion of all formalities,” it added.
AGP Limited was incorporated in Pakistan as a public limited company in 2014. The company is engaged in the import, export, marketing, distribution, dealership and manufacturing of a wide array of pharmaceutical products.
Aitkenstuart Pakistan (Private) Limited (parent company) holds 55.80% of the share capital of the Company and West End 16 Pte Limited, Singapore, is the ultimate parent company.
AGP distributes its products through Muller & Phipps Pakistan (Private) Limited, which has access to over 46,000 pharmacies across Pakistan.
At the time of filing this story, the share price of AGP Limited was being traded at Rs179, down by Rs3.24 or 1.78%.
Comments